US20100070025A1 - Tubular medical endoprostheses - Google Patents

Tubular medical endoprostheses Download PDF

Info

Publication number
US20100070025A1
US20100070025A1 US12/421,777 US42177709A US2010070025A1 US 20100070025 A1 US20100070025 A1 US 20100070025A1 US 42177709 A US42177709 A US 42177709A US 2010070025 A1 US2010070025 A1 US 2010070025A1
Authority
US
United States
Prior art keywords
filament
stent
core
metal
outer member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/421,777
Inventor
Kevin R. Heath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/955,268 external-priority patent/US6290721B1/en
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US12/421,777 priority Critical patent/US20100070025A1/en
Publication of US20100070025A1 publication Critical patent/US20100070025A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/082Inorganic materials
    • A61L31/088Other specific inorganic materials not covered by A61L31/084 or A61L31/086
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18Materials at least partially X-ray or laser opaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0108Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B1/00Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/22Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting goods of particular configuration
    • D04B1/225Elongated tubular articles of small diameter, e.g. coverings or reinforcements for cables or hoses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/09Guide wires
    • A61M2025/09166Guide wires having radio-opaque features
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2101/00Inorganic fibres
    • D10B2101/20Metallic fibres
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2401/00Physical properties
    • D10B2401/04Heat-responsive characteristics
    • D10B2401/046Shape recovering or form memory
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/06Vascular grafts; stents

Definitions

  • This invention relates to tubular endoprostheses to be used inside the body.
  • Tubular endoprostheses such as medical stents are placed within the body to perform a function such as maintaining a body lumen open, for example, a passageway occluded by a tumor or a blood vessel restricted by plaque.
  • Tubular endoprostheses in the form of grafts are used to substitute for or reinforce a lumen, such as the aorta or other blood vessels which have been weakened, e.g., by an aneurysm.
  • these endoprostheses are delivered inside the body by a catheter that supports the device in a compacted or otherwise reduced-size form as it is transported to the desired site.
  • the size is particularly small when a percutaneous insertion technique is employed.
  • the endoprosthesis is expanded so that it engages the walls of the lumen.
  • the expansion mechanism may involve forcing the endoprosthesis to expand radially outwardly, for example, by inflation of a balloon carried by the catheter, to plastically deform and fix the device at a predetermined expanded position in contact with the lumen wall.
  • the expanding means, the balloon can then be deflated and the catheter removed.
  • the endoprosthesis is formed of a highly elastic material that can be reversibly compacted and expanded. During introduction into the body, the endoprosthesis is restrained in the compacted condition and upon reaching the desired site for implantation, the restraint is removed, enabling the device to self-expand by its own internal elastic restoring force.
  • X-ray fluoroscopy is used to view an endoprosthesis within the body cavity to monitor placement and operation.
  • the device may also be viewed by X-ray film after placement for medical follow-up evaluation.
  • radiopacity has limited the construction of devices to certain materials which in turn has limited the features attainable for particular applications and the available insertion techniques.
  • metal such as in the form of wire or filament or the like is used for constructing tubular medical endoprosthesis such as stents.
  • Desirable attributes of these wires vary with the stent application, but include properties such as stiffness, tensile strength, elasticity, radiopacity, weldability, flexural life, conductivity, etc. These properties are hard to find in conventional wires.
  • desired properties are achieved by creating a multiple metal coaxial construction. For example, it may be very desirable to have high radiopacity along with elasticity and strength. This is accomplished by combining a radiopaque metal with an elastic metal.
  • the dense radiopaque material e.g., tantalum
  • the elastic material e.g., titanium or nickel-titanium alloy
  • an aspect of the invention is a metal stent device with at least a portion to be used within the body having properties that can be tailored to a particular application.
  • the portion within the body is formed of preferably two or more dissimilar metals joined together to form a unitary member.
  • each metal contributes a desirable property to the device which is not substantially impaired by the presence of the other metal.
  • one metal provides enhanced radiopacity.
  • the stent is comprised of a metal outer member having a predetermined density and an exposed outer surface and a core including a metal having a density greater than the outer member to enhance radiopacity. The core is secured within and substantially enclosed by the outer member.
  • the stent is configured such that the mechanical properties, for example, the elastic properties, of the metal forming the outer member are affected by the core to a desired degree so that the stent has a desired overall performance suitable for its intended use.
  • the mechanical properties of the outer member dominate the properties of the stent yet the radiopacity of the member is substantially enhanced by the denser core.
  • the invention also allows increased radiopacity of the stent without adversely affecting and in some cases improving other important properties such as the biocompatibility, small size or other performance characteristics.
  • An aspect of the invention features a tubular prosthesis device for use within the body.
  • Forming the tubular endoprosthesis is a metal filament material comprised of a metal outer member of extended length having an exposed outer surface and a core within the extended outer member formed of a different metal than the outer member. The core is secured within and substantially enclosed by the outer member.
  • the device is capable of reduction to a small size for introduction into the body lumen and expandable to a sufficiently large size to engage the wall of the body lumen.
  • the outer member and core are such that the endoprosthesis is elastic and capable of radial reduction in size without plastic deformation to the small size for introduction to the body and self-expandable by an internal elastic self-restoring force to the large size for engaging the wall of the lumen.
  • the outer member and core are such that the endoprosthesis is plastically deformable; it is formed of small size for introduction into the body and expandable by plastic deformation to the large size for engaging the wall of the lumen.
  • the device is formed into the tubular shape by knitting of the wire or filament into loosely interlocked loops of the filament.
  • the metal of the core has a density greater than the metal of the outer member of the device.
  • the cross sectional dimension of the filament is about 0.015 inch or less.
  • the cross-sectional dimension of the filament is about 0.006 to about 0.0045 inch and the core has a cross-sectional dimension of about 0.0014 to about 0.00195 inch.
  • the core has a density of about 9.9 g/cc or greater.
  • the core is selected form the group consisting of tungsten, tantalum, rhenium, iridium, silver, gold, bismuth and platinum.
  • the outer member is selected from superelastic alloys and precursors of superelastic alloys and stainless steel.
  • the outer member is nitinol.
  • the core is tantalum.
  • Another, particular aspect of the invention features a self-expanding tubular prosthesis device for use within the body formed of loosely interlocked knitted loops of a metal filament material.
  • the filament is formed of an elastic metal capable of deflection without plastic deformation to produce a self-restoring force.
  • the filament material is formed of an elastic metal outer member of extended length having high elasticity and an exposed outer surface, and a core of a different metal than the outer member, which core is secured within and substantially enclosed by the outer member.
  • the device is capable of reduction to a small size for introduction into the body lumen and expandable by the internal restoring force to a sufficiently large size to engage the wall of the body lumen.
  • the core is about 25% or more of the cross-sectional dimension.
  • the core is between about 1 and 40%, e.g. about 28% or less, preferably 33% of the cross-sectional dimension.
  • the core has a modulus of elasticity of about 500 GPa or less, such as about 200 GPa or less.
  • the invention features a medical stent device capable of placement or manipulation in the body by means external of the body under guidance of a fluoroscope.
  • the device is at least in part an elongated filament-form metal member adapted to be subjected to elastic deformation to enable the device to be forced into a characteristic deformed configuration during a stage of use and to elastically self-recover from the deformation when deformation forces are relieved.
  • the filament-form metal member includes a core of a first metal of a first selected thickness and an intimately surrounding sheath of a second selected metal of a second thickness.
  • the first metal is a high density metal that demonstrates characteristic relatively high radiopacity and the second metal is a lower density metal having substantially more elasticity than the first metal.
  • the combined effect of the selected thicknesses of the first and second metals in the filament-form member serves to enhance the radio-opacity of the filament-form member to provide improved fluoroscopic or x-ray visualization of the filament-form member in the body while imparting sufficient elasticity to enable the filament-form member to elastically self-recover from its characteristic deformed configuration.
  • the invention features a tubular endoprosthesis formed of a metal member.
  • the metal member has a cross-sectional thickness of about 0.015 inch or less, more preferably 0.0075 inch or less, and is composed of at least two different metals, including an exposed outer metal having selected mechanical properties and an inner metal encompassed within the outer metal, the inner metal having a relatively high density compared to the outer metal for enhancing the radiopacity of the endoprosthesis.
  • the filament is formed by draw-forming techniques employing a large starting member which has a core of metal of different properties than a surrounding metal shell.
  • the invention also includes methods for the use and construction of the endoprostheses described.
  • FIG. 1 is a perspective view of a stent according to the invention, while FIG. 1 a is an enlarged view of adjacent loops of a filament knitted to form the stent;
  • FIG. 2 is a highly enlarged schematic cross-sectional view of the stent filament in FIG. 1 a across the lines 22 ; while FIG. 2 a is a similarly enlarged longitudinal cross-sectional view of a portion of the filament;
  • FIG. 3 is a schematic longitudinal cross-sectional view of a stent filament according to FIG. 2 in a bent configuration
  • FIGS. 4 to 4 b illustrate placement of a self-expanding stent according to the invention
  • FIGS. 5 to 5 b illustrate placement of a plastically deformable stent according to the invention
  • FIG. 6 is a graph of load as a function of displacement for several stent wires according to the invention.
  • FIG. 7 is an enlarged schematic cross-sectional view of a stent filament.
  • an endoprosthesis stent 10 is adapted for use in the biliary tree and formed of an elastic filament 11 knitted into a mesh cylinder 12 that extends to ends 14 , 14 ′ coaxially along axis 13 over a working length L, about 4-6 cm and has a maximum expanded diameter, D, of about 9-10 mm.
  • the knitting forms a series of loosely interlocked knitted loops (e.g., as indicated by adjacent loops 16 , 16 ′, FIG. 1 a ) which may slide with respect to each other when the stent is radially compacted, for example, when delivered into the biliary duct on a catheter as further discussed below.
  • the filament 11 is a wire-form member that includes a longitudinal outer member 4 concentrically disposed about a central core 8 which extends along an axis 6 .
  • the longitudinal member 4 having an outer diameter, d.sub.o about 0.0052 inch, is formed of a metal, such as nitinol, that exhibits desirable properties, such as high elasticity and biocompatibility of its exposed outer surface 7 .
  • the surface 7 may include a non-metal coating of, e.g., fluorocarbons, silicones, hydrophilic and lubricous biocompatible materials.
  • the core 8 is bonded to and substantially enclosed by the outer member 4 such that the core does not have any substantial exposed surface and therefore does not contact body tissue when positioned within the body during use.
  • the core 8 is a continuous solid member in intimate contact with and bonded to the interior portions of the outer member 4 without the formation of substantial voids in the interface 10 between the core and outer member.
  • the elastic properties of the filament 11 are dominated by the elastic properties of the longitudinal member 4 .
  • the core material 8 enhances the radiopacity of the filament 11 but preferably does not substantially affect the mechanical performance of the filament.
  • a stent can be formed of a composite filament exhibiting substantially the elasticity properties of, for example, a solid elastic (used in linear range) or superelastic nitinol filament, (to form, for example, a self-expanding stent), despite the presence of a dense, e.g. tantalum, core, and that the stent formed of the composite filament is more radiopaque than a stent formed of a solid nitinol filament.
  • the filament 11 is shown in a bent position, as it may be, for example when in use in a knitted stent device.
  • the inner and outer portions (I) and (O), respectively, experience a wide range of compression and tension, as the filament is bent such as during knitting of the stent and during placement of the stent and in use.
  • An advantage of the filament is that by positioning the radiopaque core material 8 near the axis 6 , the range of tension and compression imposed on the core is relatively small and a wide latitude of stiff, dense, strong, and/or substantially radiopaque materials can be used which otherwise might not be suitable for their response to bending or other properties.
  • stents of the invention are for the biliary tree (e.g. 8 -12 mm diameter, 2-8 cm length) such as the hepatic and pancreatic duct (e.g. 4-12 mm diameter), the urinary tract including the prostate and urethra (e.g. 14-15 mm, diameter; 3-4 cm, length) and the ureter (e.g. 3-4 mm diameter), and the vasculature including the hepatic vasculature e.g. for the treatment of portal hypertension (e.g.
  • a filament with a larger outer diameter, d.sub.o may be used for larger stents.
  • a filament outer diameter, d.sub.o in the range of 0.008 inch may be used in the case of an aortic stent.
  • the dimension of the core (d.sub.c) is less than about 50% (but typically greater than about 1%) of the outer diameter of the filament, more preferably between about 40% and 25%, for example about 33%.
  • Embodiments of the stent having enhanced radiopacity are especially useful in applications where the stent must be sized small with, for example, a stent wire outer diameter (d.sub.o) of less than about 0.015 inch, e.g., even less than 0.0075 inch and for which less dense metals are required for advantageous elastic properties.
  • the filament is formed of nitinol with an outer diameter, d.sub.o, of about 0.006 inch and a core of tantalum with diameter, d.sub.c, at about 0.002 inch.
  • stent 10 is a self-expanding stent that may be introduced to a body lumen 20 such as the biliary tree.
  • the stent 10 is positioned on a catheter 24 which includes a sleeve 26 to maintain the stent 10 in a relatively compact form ( FIG. 4 ). This is typically achieved by rolling the stent upon itself and a pair of tiny mandrels that nip a portion of the wall of the stent and are rotated bodily together until the full circumference of the stent is taken up in the resulting rolled up form.
  • the stent may be positioned coaxially over the catheter.
  • the catheter is positioned within the lumen at the region corresponding to a tumor 22 and the sleeve 26 is removed from about the stent 10 , for example, by withdrawing axially in the direction of arrow 28 , thus causing the stent 10 to radially expand by release of its internal restoring force ( FIG. 4 a ).
  • the internal restoring force is sufficient to dilate the lumen 20 by pushing the tumor growth 22 radially outward (or in some cases compressing the occlusion against the lumen wall), thus opening a passage that allows unobstructed flow through the lumen and allowing removal of the catheter 24 ( FIG. 4 b ).
  • the stent may be compressed in a tube having a distal axial opening and be pushed from the end of the tube, whereby it self-expands.
  • the stent may also be a plastically deformable tube-like knitted structure 50 .
  • the individual filament meshes interlock loosely in a looped pattern and during radial expansion of the knitted structure loops forming the individual meshes are deformed beyond the elastic limits of the filament, resulting in plastic deformation of the filament.
  • Stent 50 is placed over a balloon 51 carried near the distal end of a catheter 52 .
  • the catheter 52 is directed through a lumen 54 , e.g., a blood vessel until the portion carrying the balloon and stent reaches the region of the occlusion 53 ( FIG. 5 ).
  • the stent 50 is then radially expanded beyond its elastic limit by the admission of pressure to the balloon 51 and compressed against the vessel wall with the result that occlusion 53 is compressed, and the vessel wall surrounding it undergoes a radial expansion ( FIG. 5 a ).
  • the pressure is then released from the balloon and the catheter is withdrawn from the vessel ( FIG. 5 b ).
  • the stent in the balloon expandable embodiment is preferably formed with a dense radiopaque core formed of tantalum and an outer member formed of plastically deformable stainless steel. While the stent filament is plastically deformable, the filament may be selected to have elasticity sufficient to meet the needs of the particular vessel.
  • self-expanding stents such as discussed above with respect to FIG. 4 et seq. can be used with a balloon delivery system to aid dilatation of a body lumen.
  • the metals used in the filament and their configuration are selected to exhibit various desirable characteristics.
  • the relative dimension of the core and outer member and the particular materials used for these elements may be selected based on the desired over-all mechanical properties of the stent and the degree to which x-ray visibility is to be enhanced, since the core affects the mechanical properties of the filament compared to a solid filament formed of the outer material, and the radiopacity is a function of the sum of the mass between an x-ray beam source and detector.
  • a knitted stent with overlapping portions may require less radiopaque material to provide sufficient visibility.
  • the location of use in the body may affect the amount of dense material needed for sufficient visibility.
  • the visibility of a device can be tested by known techniques such as ASTM Designation F640-79 “Standard Test Method for Radiopacity of Plastics for Medical Use”. In this test, the background densities which may be encountered clinically are mimicked by an aluminum plate positioned over the stent having various thicknesses.
  • the properties of the outer member metal and core which may be considered include density, modulus of elasticity (in annealed and hardened states), biocompatability (primarily a factor for the material of the outer longitudinal member), flexural stiffness, durability, tensile and compression strength, and the required radiopacity and resolution.
  • the inner and outer metals may be the same metal or metals of the same elemental composition that are different metals because of e.g., different crystal structure or other properties.
  • the outer member is formed of a continuous solid mass of a highly elastic biocompatible metal such as a superelastic or pseudo-elastic metal alloy, for example, a nitinol (e.g., 55% nickel, 45% titanium).
  • a highly elastic biocompatible metal such as a superelastic or pseudo-elastic metal alloy, for example, a nitinol (e.g., 55% nickel, 45% titanium).
  • superelastic materials include, e.g., Silver-Cadmium (Ag—Cd), Gold-Cadmium (Au—Cd), Gold-Copper-Zinc (Au—Cu—Zn), Copper-Aluminum-Nickel (Cu—Al—Ni), Copper-Gold-Zinc (Cu—Au—Zn), Copper-Zinc (Cu—Zn), Copper-Zinc-aluminum (Cu—Zn—Al), Copper-Zinc-Tin (Cu—Zn—Sn), Copper-Zinc-Xenon (Cu—Zn—Xe), Iron Beryllium (Fe.sub.3Be), Iron Platinum (Fe.sub.3Pt), Indium-Thallium (In—Tl), iron-manganese (Fe—Mn) Nickel-Titanium-Vanadium (Ni—Ti—V), Iron-Nickel-Titanium-Cobalt (Fe—Ni—Ti—Co)
  • nitinol or other highly elastic metal is employed as the outer member, in an arrangement in which it is never stressed beyond the straight line portion of its stress strain curve.
  • metals suitable for the outer member include stainless steel or the precursor of superelastic alloys.
  • Precursors of superelastic alloys are those alloys which have the same chemical constituents as superelastic alloys, but have not been processed to impart the superelastic property under the conditions of use.
  • the core material is preferably a continuous solid mass, but may also be in a powder-form.
  • the core includes a metal that is relatively dense to enhance radiopacity.
  • the core metal has a density of about 9.9 g/cc or greater.
  • Other preferred materials and their density include tungsten (19.3 g/cc), rhenium (21.2 g/cc), bismuth (9.9 g/cc), silver (16.49 g/cc), gold (19.3 g/cc), platinum (21.45 g/cc), and iridium (22.4 g/cc).
  • the core is somewhat stiffer than the outer member.
  • the core metal has a low modulus of elasticity, e.g., preferably below about 550 GPa, e.g., such as tantalum (186 GPa).
  • a smaller difference between the modulus of elasticity between the outer material and core results in a smaller variation of the modulus from that of the outer material in the filament of the invention.
  • a smaller core may be used so as to produce a filament in which the elastic properties are dominated by the outer material.
  • the outer member and core may be in many cross-sectional geometric configurations, such as circular, square, triangular, hexagonal, octagonal, trapezoidal and the geometrical configuration of the core may differ from that of the longitudinal member.
  • the outer member of a filament may be rectangular in cross-section with a rectangular core or triangular or hexagonal in cross-section with a circular core.
  • a stent filament may also take on the form of tubing with a lumen within the core extending along the axis.
  • a stent filament may also include successive layers of less dense outer material and more dense core material to form a multi-composite system of three layers (e.g., layers 4 ′, 9 ′, 8 ′, FIG. 7 ) or more from exterior to center.
  • the core may extend intermittently along the axis in a desired pattern.
  • the filament may be a draw-form member formed, for example, by drilling out the center of a relatively large rod of the outer member material to form a bore, positioning a rod of core material in the bore, sealing the ends of the bore, e.g., by crimping, and drawing the form through a series of dies of decreasing diameter until the desired outer diameter is achieved.
  • the component may be heat treated to anneal, harden or impart superelastic properties. Other methods of formation are also possible, e.g., by coating the core with the desired outer material such as by electro- or electroless plating.
  • the materials used in the outer member and core are also selected based on their workability for forming the filament, including factors such as machinability, for forming the longitudinal member into a tubular piece and the core member into a rod shaped piece, stability in gaseous environments at annealing temperatures, properties related to drawing, welding, forging; swaging, the ability to accept coatings such as adhesives, polymers, lubricants and practical aspects such as cost and availability.
  • the stents of the invention are preferably constructed by knitting a filament, most preferably on a circular knitting machine. Knitted metal stents are discussed, for example, in Strecker, U.S. Pat. No. 4,922,905. It will be appreciated that the stent may be formed from a composite metal filament by other means such as weaving, crocheting, or forming the filament into a spiral-spring form element. It will further be appreciated that the composite filament may be incorporated within a stent formed from conventional metal or non-metal materials (e.g. dacron in the case of an aortic graft) to contribute desirable properties such as strength and/or radiopacity. The stent may also be in the form of a metal member configured as other than a filament-form, e.g., a composite sheet form member in the form of a cuff or tube.
  • the following example is illustrative of a stent filament.
  • An elastic, radiopaque filament for use in a stent may be formed as follows.
  • a 500 foot length of filament (0.0052 inch in diameter) having an outer member formed of a precursor of a nitinol (55% Ni/45% Ti) superelastic alloy and a core material of tantalum (0.00175 inch in diameter) is formed by drilling a 0.25 inch diameter bore in a 0.75 inch rod of the outer member material and providing in the drilled lumen a tantalum member of substantially matched outer diameter.
  • the rod is mechanically forged in a standard hot forging and rolling apparatus, then hammered such that no substantial voids between the core and outer longitudinal member are present.
  • One end of the rod is sealed and the opposite end is cold drawn longitudinally through a die to the final diameter.
  • the outer member of the filament is the precursor of a superelastic alloy, i.e., it has not been heat treated to impart the superelastic property under the anticipated conditions of use.
  • curves C, D and A are offset, successively, 0.025 inch on the x-axis.
  • Curve A illustrates the filament as discussed in the above paragraph prior to heat annealing which induces the superelastic property; the filament exhibits substantially linear elastic strain as a function of stress to a break point z.
  • Curves B, C, D illustrate stress/strain curves after annealing the filament at 460.degree. C. for 3 minutes, 5 minutes and 15 minutes, respectively. As these curves illustrate, the superelastic nature of the filament is substantially preserved, as evidenced by the substantial plateaus (p) on the stress/strain curve, despite the presence of the tantalum core.
  • the stress at which constant displacement occurs decreases with increasing annealing, as would be expected with a superelastic material.
  • the mechanical properties of the filament therefore, are dominated by the nitinol alloy, despite the presence of the tantalum core.
  • the modulus of elasticity of the filaments of the invention was varied less than 30% compared to the solid Ni—Ti filament.
  • the plateau stress of the filaments of the invention using a superelastic outer member was varied less than about 10% compared to a solid Ni—Ti superelastic filament.
  • the composite filament formed as described exhibits about 30% or more enhanced x-ray visibility over a filament of the same thickness formed of solid nitinol.
  • filaments may be employed both in instances where the superelastic property is employed, and in instances where it is not (all stress within the straight line portion of the stress strain curve).
  • filaments as described dominated by the mechanical properties of an outer member, such as nitinol, and exhibiting generally satisfactory radiopacity have outer diameter (d.sub.o) of about 0.008 to 0.0045 inch with a core, for example of tantalum, with diameter (d.sub.c) of about 0.0014 to 0.00195 inch.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Textile Engineering (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A tubular prosthesis device for use within the body. The device includes, a metal filament material formed of metal outer member having an exposed outer surface and a core within the extended outer member formed of a different metal than the outer member. The core is secured within and substantially enclosed by the outer member. The device can be reduced to a small size for introduction into the body lumen and expandable to a sufficiently large size to engage the wall of the body lumen. Stents formed of composite wires are shown.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 10/751,749, filed Jan. 5, 2004, which is a continuation of application Ser. No. 09/924,275, filed Aug. 8, 2001, now U.S. Pat. No. 7,101,392, which is a continuation of U.S. application Ser. No. 09/076,520, filed May 12, 1998, now U.S. Pat. No. 6,287,331, which is a continuation of U.S. application Ser. No. 08/955,268, filed Oct. 21, 1997, now U.S. Pat. No. 6,290,721, which is a continuation of U.S. application Ser. No. 08/478,007, filed Jun. 7, 1995, now abandoned, which is a continuation of U.S. application Ser. No. 08/282,776, filed Jul. 29, 1994, now abandoned, which is a continuation of U.S. application Ser. No. 07/910,631, filed Jul. 8, 1992, now abandoned, which is a continuation-in-part of U.S. application Ser. No. 07/861,253, filed Mar. 21, 1992, now abandoned.
  • FIELD OF THE INVENTION
  • This invention relates to tubular endoprostheses to be used inside the body.
  • BACKGROUND OF THE INVENTION
  • Tubular endoprostheses such as medical stents are placed within the body to perform a function such as maintaining a body lumen open, for example, a passageway occluded by a tumor or a blood vessel restricted by plaque. Tubular endoprostheses in the form of grafts are used to substitute for or reinforce a lumen, such as the aorta or other blood vessels which have been weakened, e.g., by an aneurysm.
  • Typically, these endoprostheses are delivered inside the body by a catheter that supports the device in a compacted or otherwise reduced-size form as it is transported to the desired site. The size is particularly small when a percutaneous insertion technique is employed. Upon reaching the site, the endoprosthesis is expanded so that it engages the walls of the lumen.
  • The expansion mechanism may involve forcing the endoprosthesis to expand radially outwardly, for example, by inflation of a balloon carried by the catheter, to plastically deform and fix the device at a predetermined expanded position in contact with the lumen wall. The expanding means, the balloon, can then be deflated and the catheter removed.
  • In another technique, the endoprosthesis is formed of a highly elastic material that can be reversibly compacted and expanded. During introduction into the body, the endoprosthesis is restrained in the compacted condition and upon reaching the desired site for implantation, the restraint is removed, enabling the device to self-expand by its own internal elastic restoring force.
  • In many cases, X-ray fluoroscopy is used to view an endoprosthesis within the body cavity to monitor placement and operation. The device may also be viewed by X-ray film after placement for medical follow-up evaluation. To date, the requirement for radiopacity has limited the construction of devices to certain materials which in turn has limited the features attainable for particular applications and the available insertion techniques.
  • SUMMARY OF THE INVENTION
  • In the invention, metal such as in the form of wire or filament or the like is used for constructing tubular medical endoprosthesis such as stents. Desirable attributes of these wires vary with the stent application, but include properties such as stiffness, tensile strength, elasticity, radiopacity, weldability, flexural life, conductivity, etc. These properties are hard to find in conventional wires. According to the invention, desired properties are achieved by creating a multiple metal coaxial construction. For example, it may be very desirable to have high radiopacity along with elasticity and strength. This is accomplished by combining a radiopaque metal with an elastic metal. Although it is possible to put either metal on the inside or outside, it is preferable to put the dense radiopaque material (e.g., tantalum) on the inside (core) since dense materials are generally less elastic and the elastic material (e.g., titanium or nickel-titanium alloy) on the outside (clad). The clad or “skin” of the wire will undergo more deformation in bending than the core, so the elastic component is best positioned at the skin.
  • Thus, an aspect of the invention is a metal stent device with at least a portion to be used within the body having properties that can be tailored to a particular application. The portion within the body is formed of preferably two or more dissimilar metals joined together to form a unitary member. Typically, each metal contributes a desirable property to the device which is not substantially impaired by the presence of the other metal. In particularly preferred devices, one metal provides enhanced radiopacity. In these embodiments, the stent is comprised of a metal outer member having a predetermined density and an exposed outer surface and a core including a metal having a density greater than the outer member to enhance radiopacity. The core is secured within and substantially enclosed by the outer member. Preferably, the stent is configured such that the mechanical properties, for example, the elastic properties, of the metal forming the outer member are affected by the core to a desired degree so that the stent has a desired overall performance suitable for its intended use. Preferably, the mechanical properties of the outer member dominate the properties of the stent yet the radiopacity of the member is substantially enhanced by the denser core. The invention also allows increased radiopacity of the stent without adversely affecting and in some cases improving other important properties such as the biocompatibility, small size or other performance characteristics. These performance advantages can be realized by proper selection of the material of the outer member and core, their relative size, and geometrical configuration. The particular performance characteristics to be achieved are dictated by the stent application.
  • The term “metal” as used herein includes electropositive chemical elements characterized by ductility, malleability, luster, and conductivity of heat and electricity, which can replace the hydrogen of an acid and forms bases with the hydroxyl radical and including mixtures including these elements and alloys. Many examples are given below. An aspect of the invention features a tubular prosthesis device for use within the body. Forming the tubular endoprosthesis is a metal filament material comprised of a metal outer member of extended length having an exposed outer surface and a core within the extended outer member formed of a different metal than the outer member. The core is secured within and substantially enclosed by the outer member. The device is capable of reduction to a small size for introduction into the body lumen and expandable to a sufficiently large size to engage the wall of the body lumen.
  • In some preferred embodiments, the outer member and core are such that the endoprosthesis is elastic and capable of radial reduction in size without plastic deformation to the small size for introduction to the body and self-expandable by an internal elastic self-restoring force to the large size for engaging the wall of the lumen.
  • In other embodiments, the outer member and core are such that the endoprosthesis is plastically deformable; it is formed of small size for introduction into the body and expandable by plastic deformation to the large size for engaging the wall of the lumen.
  • Various embodiments of the invention may also include one or more of the following features. The device is formed into the tubular shape by knitting of the wire or filament into loosely interlocked loops of the filament. The metal of the core has a density greater than the metal of the outer member of the device. The cross sectional dimension of the filament is about 0.015 inch or less. The cross-sectional dimension of the filament is about 0.006 to about 0.0045 inch and the core has a cross-sectional dimension of about 0.0014 to about 0.00195 inch. The core has a density of about 9.9 g/cc or greater. The core is selected form the group consisting of tungsten, tantalum, rhenium, iridium, silver, gold, bismuth and platinum. The outer member is selected from superelastic alloys and precursors of superelastic alloys and stainless steel. The outer member is nitinol. The core is tantalum.
  • Another, particular aspect of the invention features a self-expanding tubular prosthesis device for use within the body formed of loosely interlocked knitted loops of a metal filament material. The filament is formed of an elastic metal capable of deflection without plastic deformation to produce a self-restoring force. The filament material is formed of an elastic metal outer member of extended length having high elasticity and an exposed outer surface, and a core of a different metal than the outer member, which core is secured within and substantially enclosed by the outer member. The device is capable of reduction to a small size for introduction into the body lumen and expandable by the internal restoring force to a sufficiently large size to engage the wall of the body lumen.
  • Various embodiments of this aspect as well as other aspects may include the features already mentioned as well as one or more of the following features. The core is about 25% or more of the cross-sectional dimension. The core is between about 1 and 40%, e.g. about 28% or less, preferably 33% of the cross-sectional dimension. The core has a modulus of elasticity of about 500 GPa or less, such as about 200 GPa or less.
  • In another aspect the invention features a medical stent device capable of placement or manipulation in the body by means external of the body under guidance of a fluoroscope. The device is at least in part an elongated filament-form metal member adapted to be subjected to elastic deformation to enable the device to be forced into a characteristic deformed configuration during a stage of use and to elastically self-recover from the deformation when deformation forces are relieved. The filament-form metal member includes a core of a first metal of a first selected thickness and an intimately surrounding sheath of a second selected metal of a second thickness. The first metal is a high density metal that demonstrates characteristic relatively high radiopacity and the second metal is a lower density metal having substantially more elasticity than the first metal. The combined effect of the selected thicknesses of the first and second metals in the filament-form member serves to enhance the radio-opacity of the filament-form member to provide improved fluoroscopic or x-ray visualization of the filament-form member in the body while imparting sufficient elasticity to enable the filament-form member to elastically self-recover from its characteristic deformed configuration.
  • In another aspect, the invention features a tubular endoprosthesis formed of a metal member. The metal member has a cross-sectional thickness of about 0.015 inch or less, more preferably 0.0075 inch or less, and is composed of at least two different metals, including an exposed outer metal having selected mechanical properties and an inner metal encompassed within the outer metal, the inner metal having a relatively high density compared to the outer metal for enhancing the radiopacity of the endoprosthesis.
  • In various embodiments of any of the aspects of the invention the filament is formed by draw-forming techniques employing a large starting member which has a core of metal of different properties than a surrounding metal shell.
  • The invention also includes methods for the use and construction of the endoprostheses described.
  • Still other aspects of the invention will be understood from the following description and from the claims. cl DESCRIPTION OF THE PREFERRED EMBODIMENT(S)
  • We first briefly describe the drawings.
  • DRAWINGS
  • FIG. 1 is a perspective view of a stent according to the invention, while FIG. 1 a is an enlarged view of adjacent loops of a filament knitted to form the stent;
  • FIG. 2 is a highly enlarged schematic cross-sectional view of the stent filament in FIG. 1 a across the lines 22; while FIG. 2 a is a similarly enlarged longitudinal cross-sectional view of a portion of the filament;
  • FIG. 3 is a schematic longitudinal cross-sectional view of a stent filament according to FIG. 2 in a bent configuration;
  • FIGS. 4 to 4 b illustrate placement of a self-expanding stent according to the invention;
  • FIGS. 5 to 5 b illustrate placement of a plastically deformable stent according to the invention;
  • FIG. 6 is a graph of load as a function of displacement for several stent wires according to the invention.
  • FIG. 7 is an enlarged schematic cross-sectional view of a stent filament.
  • DESCRIPTION
  • Referring to FIGS. 1 and 1 a, an endoprosthesis stent 10 according to a preferred embodiment is adapted for use in the biliary tree and formed of an elastic filament 11 knitted into a mesh cylinder 12 that extends to ends 14, 14′ coaxially along axis 13 over a working length L, about 4-6 cm and has a maximum expanded diameter, D, of about 9-10 mm. The knitting forms a series of loosely interlocked knitted loops (e.g., as indicated by adjacent loops 16, 16′, FIG. 1 a) which may slide with respect to each other when the stent is radially compacted, for example, when delivered into the biliary duct on a catheter as further discussed below.
  • Referring to FIGS. 2 and 2 a, the filament 11 is a wire-form member that includes a longitudinal outer member 4 concentrically disposed about a central core 8 which extends along an axis 6. The longitudinal member 4, having an outer diameter, d.sub.o about 0.0052 inch, is formed of a metal, such as nitinol, that exhibits desirable properties, such as high elasticity and biocompatibility of its exposed outer surface 7. (The surface 7 may include a non-metal coating of, e.g., fluorocarbons, silicones, hydrophilic and lubricous biocompatible materials.) The core 8 having a diameter, dc, about 0.00175 inch, includes a metal, such as tantalum, with a density greater than the longitudinal member 4 to enhance the radiopacity of the filament and thus the stent from which it is formed. The core 8 is bonded to and substantially enclosed by the outer member 4 such that the core does not have any substantial exposed surface and therefore does not contact body tissue when positioned within the body during use. As illustrated, preferably the core 8 is a continuous solid member in intimate contact with and bonded to the interior portions of the outer member 4 without the formation of substantial voids in the interface 10 between the core and outer member. Preferably, the elastic properties of the filament 11 are dominated by the elastic properties of the longitudinal member 4. The core material 8 enhances the radiopacity of the filament 11 but preferably does not substantially affect the mechanical performance of the filament. One aspect of the present invention is that it has been discovered that a stent can be formed of a composite filament exhibiting substantially the elasticity properties of, for example, a solid elastic (used in linear range) or superelastic nitinol filament, (to form, for example, a self-expanding stent), despite the presence of a dense, e.g. tantalum, core, and that the stent formed of the composite filament is more radiopaque than a stent formed of a solid nitinol filament.
  • Referring to FIG. 3, the filament 11 is shown in a bent position, as it may be, for example when in use in a knitted stent device. The inner and outer portions (I) and (O), respectively, experience a wide range of compression and tension, as the filament is bent such as during knitting of the stent and during placement of the stent and in use. An advantage of the filament is that by positioning the radiopaque core material 8 near the axis 6, the range of tension and compression imposed on the core is relatively small and a wide latitude of stiff, dense, strong, and/or substantially radiopaque materials can be used which otherwise might not be suitable for their response to bending or other properties.
  • Parameter Selection
  • Generally, the characteristics of the filament and thus the selection of the outer member and core metals, is based on the stent application. Particularly preferred uses of stents of the invention are for the biliary tree (e.g. 8 -12 mm diameter, 2-8 cm length) such as the hepatic and pancreatic duct (e.g. 4-12 mm diameter), the urinary tract including the prostate and urethra (e.g. 14-15 mm, diameter; 3-4 cm, length) and the ureter (e.g. 3-4 mm diameter), and the vasculature including the hepatic vasculature e.g. for the treatment of portal hypertension (e.g. 4-10 mm diameter; 5-6 cm, length), the neurovasculature (e.g. 1 mm, diameter) and the aorta (e.g. 20 mm, diameter) for example, for treatment of aneurysms or lesions. A filament with a larger outer diameter, d.sub.o, may be used for larger stents. For example, a filament outer diameter, d.sub.o, in the range of 0.008 inch may be used in the case of an aortic stent.
  • Typically, the dimension of the core (d.sub.c) is less than about 50% (but typically greater than about 1%) of the outer diameter of the filament, more preferably between about 40% and 25%, for example about 33%. Embodiments of the stent having enhanced radiopacity are especially useful in applications where the stent must be sized small with, for example, a stent wire outer diameter (d.sub.o) of less than about 0.015 inch, e.g., even less than 0.0075 inch and for which less dense metals are required for advantageous elastic properties. For example, in another embodiment the filament is formed of nitinol with an outer diameter, d.sub.o, of about 0.006 inch and a core of tantalum with diameter, d.sub.c, at about 0.002 inch. Referring to FIGS. 4 to 4 b, in embodiments such as that discussed with respect to
  • FIGS. 1 and 1 a, stent 10 is a self-expanding stent that may be introduced to a body lumen 20 such as the biliary tree. The stent 10 is positioned on a catheter 24 which includes a sleeve 26 to maintain the stent 10 in a relatively compact form (FIG. 4). This is typically achieved by rolling the stent upon itself and a pair of tiny mandrels that nip a portion of the wall of the stent and are rotated bodily together until the full circumference of the stent is taken up in the resulting rolled up form. In other cases, the stent may be positioned coaxially over the catheter. The catheter is positioned within the lumen at the region corresponding to a tumor 22 and the sleeve 26 is removed from about the stent 10, for example, by withdrawing axially in the direction of arrow 28, thus causing the stent 10 to radially expand by release of its internal restoring force (FIG. 4 a). The internal restoring force is sufficient to dilate the lumen 20 by pushing the tumor growth 22 radially outward (or in some cases compressing the occlusion against the lumen wall), thus opening a passage that allows unobstructed flow through the lumen and allowing removal of the catheter 24 (FIG. 4 b).
  • In another embodiment, the stent may be compressed in a tube having a distal axial opening and be pushed from the end of the tube, whereby it self-expands.
  • Referring now to FIGS. 5 to 5 b, the stent may also be a plastically deformable tube-like knitted structure 50. The individual filament meshes interlock loosely in a looped pattern and during radial expansion of the knitted structure loops forming the individual meshes are deformed beyond the elastic limits of the filament, resulting in plastic deformation of the filament. Stent 50 is placed over a balloon 51 carried near the distal end of a catheter 52. The catheter 52 is directed through a lumen 54, e.g., a blood vessel until the portion carrying the balloon and stent reaches the region of the occlusion 53 (FIG. 5). The stent 50 is then radially expanded beyond its elastic limit by the admission of pressure to the balloon 51 and compressed against the vessel wall with the result that occlusion 53 is compressed, and the vessel wall surrounding it undergoes a radial expansion (FIG. 5 a). The pressure is then released from the balloon and the catheter is withdrawn from the vessel (FIG. 5 b).
  • The stent in the balloon expandable embodiment is preferably formed with a dense radiopaque core formed of tantalum and an outer member formed of plastically deformable stainless steel. While the stent filament is plastically deformable, the filament may be selected to have elasticity sufficient to meet the needs of the particular vessel. In addition, self-expanding stents, such as discussed above with respect to FIG. 4 et seq. can be used with a balloon delivery system to aid dilatation of a body lumen.
  • In various embodiments, the metals used in the filament and their configuration are selected to exhibit various desirable characteristics. For example, the relative dimension of the core and outer member and the particular materials used for these elements may be selected based on the desired over-all mechanical properties of the stent and the degree to which x-ray visibility is to be enhanced, since the core affects the mechanical properties of the filament compared to a solid filament formed of the outer material, and the radiopacity is a function of the sum of the mass between an x-ray beam source and detector. A knitted stent with overlapping portions, may require less radiopaque material to provide sufficient visibility. Similarly, the location of use in the body may affect the amount of dense material needed for sufficient visibility. The visibility of a device can be tested by known techniques such as ASTM Designation F640-79 “Standard Test Method for Radiopacity of Plastics for Medical Use”. In this test, the background densities which may be encountered clinically are mimicked by an aluminum plate positioned over the stent having various thicknesses.
  • The properties of the outer member metal and core which may be considered include density, modulus of elasticity (in annealed and hardened states), biocompatability (primarily a factor for the material of the outer longitudinal member), flexural stiffness, durability, tensile and compression strength, and the required radiopacity and resolution.
  • In some cases, if desirable, the inner and outer metals may be the same metal or metals of the same elemental composition that are different metals because of e.g., different crystal structure or other properties.
  • In other embodiments of elastic filament members, the outer member is formed of a continuous solid mass of a highly elastic biocompatible metal such as a superelastic or pseudo-elastic metal alloy, for example, a nitinol (e.g., 55% nickel, 45% titanium). Other examples of superelastic materials include, e.g., Silver-Cadmium (Ag—Cd), Gold-Cadmium (Au—Cd), Gold-Copper-Zinc (Au—Cu—Zn), Copper-Aluminum-Nickel (Cu—Al—Ni), Copper-Gold-Zinc (Cu—Au—Zn), Copper-Zinc (Cu—Zn), Copper-Zinc-aluminum (Cu—Zn—Al), Copper-Zinc-Tin (Cu—Zn—Sn), Copper-Zinc-Xenon (Cu—Zn—Xe), Iron Beryllium (Fe.sub.3Be), Iron Platinum (Fe.sub.3Pt), Indium-Thallium (In—Tl), iron-manganese (Fe—Mn) Nickel-Titanium-Vanadium (Ni—Ti—V), Iron-Nickel-Titanium-Cobalt (Fe—Ni—Ti—Co) and Copper-Tin (Cu—Sn). See Schetsky, L. McDonald, “Shape Memory Alloys”, Encyclopedia of Chemical Technology (3rd ed.), John Wiley & Sons, 1982, vol. 20. pp. 726-736 for a full discussion of superelastic alloys. Preferably in some cases of elastic filament members, nitinol or other highly elastic metal is employed as the outer member, in an arrangement in which it is never stressed beyond the straight line portion of its stress strain curve. Other examples of metals suitable for the outer member include stainless steel or the precursor of superelastic alloys. Precursors of superelastic alloys are those alloys which have the same chemical constituents as superelastic alloys, but have not been processed to impart the superelastic property under the conditions of use. Such alloys are further described in co-owned and co-pending U.S. Ser. No. 07/507,375, filed Apr. 10, 1990, by R. Sahatjian (see also PCT application US91/02420) the entire contents of which is hereby incorporated by reference.
  • The core material is preferably a continuous solid mass, but may also be in a powder-form. Typically, the core includes a metal that is relatively dense to enhance radiopacity. Preferably, the core metal has a density of about 9.9 g/cc or greater. Most preferably, the core is formed of tantalum (density=16.6 g/cc). Other preferred materials and their density include tungsten (19.3 g/cc), rhenium (21.2 g/cc), bismuth (9.9 g/cc), silver (16.49 g/cc), gold (19.3 g/cc), platinum (21.45 g/cc), and iridium (22.4 g/cc). Typically, the core is somewhat stiffer than the outer member. Preferably, the core metal has a low modulus of elasticity, e.g., preferably below about 550 GPa, e.g., such as tantalum (186 GPa). Generally, a smaller difference between the modulus of elasticity between the outer material and core results in a smaller variation of the modulus from that of the outer material in the filament of the invention. For larger differences, a smaller core may be used so as to produce a filament in which the elastic properties are dominated by the outer material.
  • The outer member and core may be in many cross-sectional geometric configurations, such as circular, square, triangular, hexagonal, octagonal, trapezoidal and the geometrical configuration of the core may differ from that of the longitudinal member. For example, the outer member of a filament may be rectangular in cross-section with a rectangular core or triangular or hexagonal in cross-section with a circular core. A stent filament may also take on the form of tubing with a lumen within the core extending along the axis. A stent filament may also include successive layers of less dense outer material and more dense core material to form a multi-composite system of three layers (e.g., layers 4′, 9′, 8′, FIG. 7) or more from exterior to center. The core may extend intermittently along the axis in a desired pattern.
  • The filament may be a draw-form member formed, for example, by drilling out the center of a relatively large rod of the outer member material to form a bore, positioning a rod of core material in the bore, sealing the ends of the bore, e.g., by crimping, and drawing the form through a series of dies of decreasing diameter until the desired outer diameter is achieved. The component may be heat treated to anneal, harden or impart superelastic properties. Other methods of formation are also possible, e.g., by coating the core with the desired outer material such as by electro- or electroless plating. The materials used in the outer member and core are also selected based on their workability for forming the filament, including factors such as machinability, for forming the longitudinal member into a tubular piece and the core member into a rod shaped piece, stability in gaseous environments at annealing temperatures, properties related to drawing, welding, forging; swaging, the ability to accept coatings such as adhesives, polymers, lubricants and practical aspects such as cost and availability.
  • As evident from the above, the stents of the invention are preferably constructed by knitting a filament, most preferably on a circular knitting machine. Knitted metal stents are discussed, for example, in Strecker, U.S. Pat. No. 4,922,905. It will be appreciated that the stent may be formed from a composite metal filament by other means such as weaving, crocheting, or forming the filament into a spiral-spring form element. It will further be appreciated that the composite filament may be incorporated within a stent formed from conventional metal or non-metal materials (e.g. dacron in the case of an aortic graft) to contribute desirable properties such as strength and/or radiopacity. The stent may also be in the form of a metal member configured as other than a filament-form, e.g., a composite sheet form member in the form of a cuff or tube.
  • The following example is illustrative of a stent filament.
  • Example
  • An elastic, radiopaque filament for use in a stent may be formed as follows. A 500 foot length of filament (0.0052 inch in diameter) having an outer member formed of a precursor of a nitinol (55% Ni/45% Ti) superelastic alloy and a core material of tantalum (0.00175 inch in diameter) is formed by drilling a 0.25 inch diameter bore in a 0.75 inch rod of the outer member material and providing in the drilled lumen a tantalum member of substantially matched outer diameter. The rod is mechanically forged in a standard hot forging and rolling apparatus, then hammered such that no substantial voids between the core and outer longitudinal member are present. One end of the rod is sealed and the opposite end is cold drawn longitudinally through a die to the final diameter. Initially, the outer member of the filament is the precursor of a superelastic alloy, i.e., it has not been heat treated to impart the superelastic property under the anticipated conditions of use.
  • Referring to FIG. 6, load versus displacement curves are illustrated. (For clarity, curves C, D and A are offset, successively, 0.025 inch on the x-axis.) Curve A illustrates the filament as discussed in the above paragraph prior to heat annealing which induces the superelastic property; the filament exhibits substantially linear elastic strain as a function of stress to a break point z. Curves B, C, D illustrate stress/strain curves after annealing the filament at 460.degree. C. for 3 minutes, 5 minutes and 15 minutes, respectively. As these curves illustrate, the superelastic nature of the filament is substantially preserved, as evidenced by the substantial plateaus (p) on the stress/strain curve, despite the presence of the tantalum core. Also as illustrated, the stress at which constant displacement occurs decreases with increasing annealing, as would be expected with a superelastic material. The mechanical properties of the filament, therefore, are dominated by the nitinol alloy, despite the presence of the tantalum core.
  • Referring to Table I, the modulus of elasticity and plateau stress calculated based on stress-strain measurements as above, are compared for the filaments of the invention and a solid filament of Ni—Ti alloy.
  • TABLE I
    % Charge in
    Ni—Ti Ta Cored Ni—Ti Cored Filament
    Diameter .0038″ .0052″
    Area 1.134 × 10−5 in2 2.124 × 10−5 in2
    (Modulus of Elasticity
    Precursor 5,401,300 psi 7,373,865 psi  +27%
    460° @ 3 mins 6,967,150 psi 6,657,00 psi −4.5%
    460° @ 5 mins 5,381,160 psi 5,721,100 psi +6.0%
    460° @ 10 mins 5,139,310 psi
    460° @ 15 mins 5,143,960 psi 5,551,924 +7.4%
    Plateau Stress (loading)
    460° @ 3 mins 101,400 psi 97,174 −7.2%
    460° @ 5 mins 89,056 psi 84,757 −4.8%
    460° @ 10 mins 79,357 psi
    460° @ 15 mins 72,303 psi 75,339 psi +4.1%
  • As the results in Table I illustrate, the modulus of elasticity of the filaments of the invention was varied less than 30% compared to the solid Ni—Ti filament. The plateau stress of the filaments of the invention using a superelastic outer member was varied less than about 10% compared to a solid Ni—Ti superelastic filament. The composite filament formed as described exhibits about 30% or more enhanced x-ray visibility over a filament of the same thickness formed of solid nitinol.
  • It will be understood that such filaments may be employed both in instances where the superelastic property is employed, and in instances where it is not (all stress within the straight line portion of the stress strain curve).
  • The visibility of a knitted stent formed from the filament was greater than a comparison stent using a solid nitinol filament of larger (0.006 inch) diameter, yet using the stent of the invention, the force needed for radial compression of the stent was reduced compared to the stent formed of the thicker nitinol filament. Thus, radiopacity of the stent was enhanced while mechanical properties were dominated by the outer member, nitinol. Placement of the stent, as-described above, can be monitored by x-ray fluoroscopy.
  • Preferably, filaments as described, dominated by the mechanical properties of an outer member, such as nitinol, and exhibiting generally satisfactory radiopacity have outer diameter (d.sub.o) of about 0.008 to 0.0045 inch with a core, for example of tantalum, with diameter (d.sub.c) of about 0.0014 to 0.00195 inch.
  • Other embodiments are in the following claims.

Claims (9)

1-30. (canceled)
31. An implantable medical stent, comprising:
a first layer;
a second layer; and
a third layer,
wherein a radiopacity of the first layer is different from a radiopacity of the second layer.
32. The implantable medical stent of claim 31, wherein the radiopacity of the first layer is less than the radiopacity of the second layer.
33. The implantable medical stent of claim 32, wherein the first layer is disposed inwardly of the second layer.
34. The implantable medical stent of claim 33, wherein the second layer is disposed inwardly of third layer.
35. The implantable medical stent of claim 31, wherein the first layer comprises stainless steel.
36. The implantable medical stent of claim 31, wherein the second layer comprises a metal selected from the group consisting of tungsten, tantalum, rhenium, iridium, silver, gold, bismuth, platinum and alloys thereof.
37. The implantable medical stent of claim 31, wherein the second layer comprises a material having a density of 9.9 grams per cubic centimeter or greater.
38. The implantable medical stent of claim 31, wherein the second layer comprises a material having a density of 16 grams per cubic centimeter or greater.
US12/421,777 1992-03-31 2009-04-10 Tubular medical endoprostheses Abandoned US20100070025A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/421,777 US20100070025A1 (en) 1992-03-31 2009-04-10 Tubular medical endoprostheses

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US86125392A 1992-03-31 1992-03-31
US91063192A 1992-07-08 1992-07-08
US28277694A 1994-07-29 1994-07-29
US47800795A 1995-06-07 1995-06-07
US08/955,268 US6290721B1 (en) 1992-03-31 1997-10-21 Tubular medical endoprostheses
US09/076,520 US6287331B1 (en) 1992-03-31 1998-05-12 Tubular medical prosthesis
US09/924,275 US7101392B2 (en) 1992-03-31 2001-08-08 Tubular medical endoprostheses
US10/751,749 US20040138740A1 (en) 1992-03-31 2004-01-05 Tubular medical endoprostheses
US12/421,777 US20100070025A1 (en) 1992-03-31 2009-04-10 Tubular medical endoprostheses

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/751,749 Continuation US20040138740A1 (en) 1992-03-31 2004-01-05 Tubular medical endoprostheses

Publications (1)

Publication Number Publication Date
US20100070025A1 true US20100070025A1 (en) 2010-03-18

Family

ID=27557146

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/924,275 Expired - Fee Related US7101392B2 (en) 1992-03-31 2001-08-08 Tubular medical endoprostheses
US10/751,749 Abandoned US20040138740A1 (en) 1992-03-31 2004-01-05 Tubular medical endoprostheses
US12/421,777 Abandoned US20100070025A1 (en) 1992-03-31 2009-04-10 Tubular medical endoprostheses

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/924,275 Expired - Fee Related US7101392B2 (en) 1992-03-31 2001-08-08 Tubular medical endoprostheses
US10/751,749 Abandoned US20040138740A1 (en) 1992-03-31 2004-01-05 Tubular medical endoprostheses

Country Status (1)

Country Link
US (3) US7101392B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090192587A1 (en) * 2005-10-03 2009-07-30 Cardiatis S.A. Radio-opaque endoprosthesis

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US8579966B2 (en) 1999-11-17 2013-11-12 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US7018406B2 (en) 1999-11-17 2006-03-28 Corevalve Sa Prosthetic valve for transluminal delivery
US20070043435A1 (en) * 1999-11-17 2007-02-22 Jacques Seguin Non-cylindrical prosthetic valve system for transluminal delivery
US8016877B2 (en) 1999-11-17 2011-09-13 Medtronic Corevalve Llc Prosthetic valve for transluminal delivery
US8241274B2 (en) 2000-01-19 2012-08-14 Medtronic, Inc. Method for guiding a medical device
US6692513B2 (en) 2000-06-30 2004-02-17 Viacor, Inc. Intravascular filter with debris entrapment mechanism
US7749245B2 (en) 2000-01-27 2010-07-06 Medtronic, Inc. Cardiac valve procedure methods and devices
US8623077B2 (en) 2001-06-29 2014-01-07 Medtronic, Inc. Apparatus for replacing a cardiac valve
US7544206B2 (en) 2001-06-29 2009-06-09 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
US8771302B2 (en) 2001-06-29 2014-07-08 Medtronic, Inc. Method and apparatus for resecting and replacing an aortic valve
FR2826863B1 (en) 2001-07-04 2003-09-26 Jacques Seguin ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT
FR2828091B1 (en) 2001-07-31 2003-11-21 Seguin Jacques ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT
US7097659B2 (en) 2001-09-07 2006-08-29 Medtronic, Inc. Fixation band for affixing a prosthetic heart valve to tissue
US7011676B2 (en) 2002-09-05 2006-03-14 Scimed Life Systems, Inc. Flat knitted stent and method of making the same
US7998188B2 (en) 2003-04-28 2011-08-16 Kips Bay Medical, Inc. Compliant blood vessel graft
EP2335648A1 (en) 2003-04-28 2011-06-22 Kips Bay Medical, Inc. Compliant venous graft
US20050131520A1 (en) * 2003-04-28 2005-06-16 Zilla Peter P. Compliant blood vessel graft
US9579194B2 (en) 2003-10-06 2017-02-28 Medtronic ATS Medical, Inc. Anchoring structure with concave landing zone
ITTO20040135A1 (en) 2004-03-03 2004-06-03 Sorin Biomedica Cardio Spa CARDIAC VALVE PROSTHESIS
US20060025857A1 (en) 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
US7993387B2 (en) * 2004-05-14 2011-08-09 Boston Scientific Scimed, Inc. Stent with reduced weld profiles and a closed-end wire configuration
US8623067B2 (en) 2004-05-25 2014-01-07 Covidien Lp Methods and apparatus for luminal stenting
EP1750619B1 (en) 2004-05-25 2013-07-24 Covidien LP Flexible vascular occluding device
SG175723A1 (en) 2004-05-25 2011-12-29 Tyco Healthcare Vascular stenting for aneurysms
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
EP2407127B1 (en) 2004-11-10 2014-04-23 Boston Scientific Scimed, Inc. Atraumatic stent with reduced deployment force
US7641681B2 (en) * 2004-12-28 2010-01-05 Boston Scientific Scimed, Inc. Low profile stent-graft attachment
US20060149364A1 (en) * 2004-12-31 2006-07-06 Steven Walak Low profile vascular graft
US7727273B2 (en) * 2005-01-13 2010-06-01 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
DE102005003632A1 (en) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Catheter for the transvascular implantation of heart valve prostheses
JP5260964B2 (en) 2005-01-28 2013-08-14 ボストン サイエンティフィック リミテッド Implantable expandable band
ITTO20050074A1 (en) 2005-02-10 2006-08-11 Sorin Biomedica Cardio Srl CARDIAC VALVE PROSTHESIS
US7618362B2 (en) * 2005-03-28 2009-11-17 Boston Scientific Scimed, Inc. Spacer apparatus for radiation and ablation therapy
JP5008660B2 (en) 2005-05-13 2012-08-22 ボストン サイエンティフィック リミテッド Integrated stent repositioning and retrieval loop
US7914569B2 (en) 2005-05-13 2011-03-29 Medtronics Corevalve Llc Heart valve prosthesis and methods of manufacture and use
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
JP4945714B2 (en) 2005-05-25 2012-06-06 タイコ ヘルスケア グループ リミテッド パートナーシップ System and method for supplying and deploying an occlusion device in a conduit
US7963988B2 (en) 2005-06-23 2011-06-21 Boston Scientific Scimed, Inc. ePTFE lamination—resizing ePTFE tubing
US20070078510A1 (en) 2005-09-26 2007-04-05 Ryan Timothy R Prosthetic cardiac and venous valves
US7655035B2 (en) * 2005-10-05 2010-02-02 Boston Scientific Scimed, Inc. Variable lamination of vascular graft
CA2625264C (en) 2005-10-13 2015-12-15 Synthes (U.S.A.) Drug-impregnated sleeve for a medical implant
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
WO2007123658A1 (en) 2006-03-28 2007-11-01 Medtronic, Inc. Prosthetic cardiac valve formed from pericardium material and methods of making same
WO2007140320A2 (en) 2006-05-26 2007-12-06 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US8876894B2 (en) 2006-09-19 2014-11-04 Medtronic Ventor Technologies Ltd. Leaflet-sensitive valve fixation member
US8834564B2 (en) 2006-09-19 2014-09-16 Medtronic, Inc. Sinus-engaging valve fixation member
US11304800B2 (en) 2006-09-19 2022-04-19 Medtronic Ventor Technologies Ltd. Sinus-engaging valve fixation member
WO2008047354A2 (en) 2006-10-16 2008-04-24 Ventor Technologies Ltd. Transapical delivery system with ventriculo-arterial overflow bypass
US8105392B2 (en) * 2006-11-08 2012-01-31 Boston Scientific Scimed, Inc. Pyloric obesity valve
JP5593545B2 (en) 2006-12-06 2014-09-24 メドトロニック シーブイ ルクセンブルク エス.アー.エール.エル. System and method for transapical delivery of a self-expanding valve secured to an annulus
WO2008103280A2 (en) 2007-02-16 2008-08-28 Medtronic, Inc. Delivery systems and methods of implantation for replacement prosthetic heart valves
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
FR2915087B1 (en) 2007-04-20 2021-11-26 Corevalve Inc IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT.
US8057527B2 (en) 2007-08-09 2011-11-15 Boston Scientific Scimed, Inc. Endoprosthesis holder
US20090048657A1 (en) * 2007-08-15 2009-02-19 Boston Scientific Scimed, Inc. Preferentially varying-density ePTFE structure
US7785363B2 (en) * 2007-08-15 2010-08-31 Boston Scientific Scimed, Inc. Skewed nodal-fibril ePTFE structure
US8747458B2 (en) 2007-08-20 2014-06-10 Medtronic Ventor Technologies Ltd. Stent loading tool and method for use thereof
US9393137B2 (en) * 2007-09-24 2016-07-19 Boston Scientific Scimed, Inc. Method for loading a stent into a delivery system
US10856970B2 (en) 2007-10-10 2020-12-08 Medtronic Ventor Technologies Ltd. Prosthetic heart valve for transfemoral delivery
US9848981B2 (en) 2007-10-12 2017-12-26 Mayo Foundation For Medical Education And Research Expandable valve prosthesis with sealing mechanism
WO2009086015A2 (en) * 2007-12-21 2009-07-09 Boston Scientific Scimed, Inc. Flexible stent-graft device having patterned polymeric coverings
US8623071B2 (en) * 2008-01-07 2014-01-07 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US9149358B2 (en) 2008-01-24 2015-10-06 Medtronic, Inc. Delivery systems for prosthetic heart valves
US8157852B2 (en) 2008-01-24 2012-04-17 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US7972378B2 (en) 2008-01-24 2011-07-05 Medtronic, Inc. Stents for prosthetic heart valves
US9393115B2 (en) 2008-01-24 2016-07-19 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US8628566B2 (en) 2008-01-24 2014-01-14 Medtronic, Inc. Stents for prosthetic heart valves
EP2254512B1 (en) 2008-01-24 2016-01-06 Medtronic, Inc. Markers for prosthetic heart valves
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
EP3915525A1 (en) 2008-02-28 2021-12-01 Medtronic, Inc. Prosthetic heart valve systems
US8313525B2 (en) 2008-03-18 2012-11-20 Medtronic Ventor Technologies, Ltd. Valve suturing and implantation procedures
US8430927B2 (en) 2008-04-08 2013-04-30 Medtronic, Inc. Multiple orifice implantable heart valve and methods of implantation
US8312825B2 (en) 2008-04-23 2012-11-20 Medtronic, Inc. Methods and apparatuses for assembly of a pericardial prosthetic heart valve
US8696743B2 (en) 2008-04-23 2014-04-15 Medtronic, Inc. Tissue attachment devices and methods for prosthetic heart valves
WO2009140437A1 (en) 2008-05-13 2009-11-19 Nfocus Neuromedical, Inc. Braid implant delivery systems
US8840661B2 (en) 2008-05-16 2014-09-23 Sorin Group Italia S.R.L. Atraumatic prosthetic heart valve prosthesis
US10898620B2 (en) 2008-06-20 2021-01-26 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US8206635B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
DE102008035772B4 (en) * 2008-07-31 2015-02-12 Airbus Defence and Space GmbH Particle filter and manufacturing method thereof
WO2010031060A1 (en) 2008-09-15 2010-03-18 Medtronic Ventor Technologies Ltd. Prosthetic heart valve having identifiers for aiding in radiographic positioning
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
US8137398B2 (en) * 2008-10-13 2012-03-20 Medtronic Ventor Technologies Ltd Prosthetic valve having tapered tip when compressed for delivery
US8986361B2 (en) 2008-10-17 2015-03-24 Medtronic Corevalve, Inc. Delivery system for deployment of medical devices
ES2551694T3 (en) 2008-12-23 2015-11-23 Sorin Group Italia S.R.L. Expandable prosthetic valve with anchoring appendages
US8151682B2 (en) 2009-01-26 2012-04-10 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
EP2628465A1 (en) 2009-04-27 2013-08-21 Sorin Group Italia S.r.l. Prosthetic vascular conduit
US20100331960A1 (en) 2009-06-30 2010-12-30 Boston Scientific Scimed, Inc. Endoprosthesis and endoprosthesis delivery system and method
US9283305B2 (en) * 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
AU2010279034B2 (en) 2009-07-30 2014-09-18 Boston Scientific Scimed, Inc. Reconstrainment band with reduced removal interference
WO2011025887A1 (en) * 2009-08-27 2011-03-03 Boston Scientific Scimed, Inc. Stent with variable cross section braiding filament and method for making same
US8784473B2 (en) 2009-09-10 2014-07-22 Boston Scientific Scimed, Inc. Endoprosthesis with filament repositioning or retrieval member and guard structure
US20110070358A1 (en) 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8828474B2 (en) 2009-09-20 2014-09-09 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8381774B2 (en) 2009-09-20 2013-02-26 Medtronic Vascular, Inc. Methods for loading a drug eluting medical device
CN102548513B (en) 2009-09-21 2017-03-08 波士顿科学国际有限公司 It is applied to snare and take out and/or optimize the integral support taking-up ring that fold is evened up
US8992553B2 (en) * 2009-10-01 2015-03-31 Cardioniti Cutting balloon assembly and method of manufacturing thereof
US8808369B2 (en) 2009-10-05 2014-08-19 Mayo Foundation For Medical Education And Research Minimally invasive aortic valve replacement
EP2485689B1 (en) 2009-10-09 2020-03-18 Boston Scientific Scimed, Inc. Stomach bypass
US9226826B2 (en) 2010-02-24 2016-01-05 Medtronic, Inc. Transcatheter valve structure and methods for valve delivery
US8652204B2 (en) 2010-04-01 2014-02-18 Medtronic, Inc. Transcatheter valve with torsion spring fixation and related systems and methods
WO2011136963A1 (en) 2010-04-30 2011-11-03 Boston Scientific Scimed, Inc. Duodenal metabolic stent
EP2563295B1 (en) 2010-04-30 2020-07-01 Boston Scientific Scimed, Inc. Stent for repair of anastomasis surgery leaks
US9155643B2 (en) 2010-04-30 2015-10-13 Boston Scientific Scimed, Inc. Apparatus and method for manufacturing a single wire stent
IT1400327B1 (en) 2010-05-21 2013-05-24 Sorin Biomedica Cardio Srl SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT.
CN103002833B (en) 2010-05-25 2016-05-11 耶拿阀门科技公司 Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese
EP2611388B1 (en) 2010-09-01 2022-04-27 Medtronic Vascular Galway Prosthetic valve support structure
US8632846B2 (en) 2010-09-17 2014-01-21 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
EP2486894B1 (en) 2011-02-14 2021-06-09 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
EP2486893B1 (en) 2011-02-14 2017-07-05 Sorin Group Italia S.r.l. Sutureless anchoring device for cardiac valve prostheses
TWI590843B (en) 2011-12-28 2017-07-11 信迪思有限公司 Films and methods of manufacture
EP2842517A1 (en) 2011-12-29 2015-03-04 Sorin Group Italia S.r.l. A kit for implanting prosthetic vascular conduits
US9119736B2 (en) 2012-01-27 2015-09-01 Medtronic Vascular, Inc. Hollow drug-filled stent and method of forming hollow drug-filled stent
US9345596B2 (en) 2012-02-23 2016-05-24 Medtronic Vascular, Inc. Method of forming a nitinol stent
US9358370B2 (en) 2012-03-12 2016-06-07 Medtronic Vascular, Inc. Guidewire with integral radiopaque markers
US8998977B2 (en) 2012-04-13 2015-04-07 Medtronic Vascular, Inc. Hollow drug-filled stent and method of forming hollow drug-filled stent
US9649208B2 (en) 2012-04-13 2017-05-16 Medtronic Vascular, Inc. Hollow drug-filled stent and method of forming hollow drug-filled stent
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
DE102013100984B4 (en) * 2013-01-31 2019-03-21 Acandis Gmbh Grid mesh for a medical implant or instrument, implant and instrument with such a mesh and set with such an implant or instrument
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
WO2014151906A1 (en) 2013-03-14 2014-09-25 Medtronic Vascular Inc. Method for manufacturing a stent and stent manufactured thereby
EP2991586A1 (en) 2013-05-03 2016-03-09 Medtronic Inc. Valve delivery tool
EP3010560B1 (en) 2013-06-21 2020-01-01 DePuy Synthes Products, Inc. Films and methods of manufacture
JP6563394B2 (en) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド Radially foldable frame for an artificial valve and method for manufacturing the frame
US9622891B2 (en) 2014-04-17 2017-04-18 Abbott Cardiovascular Systems Inc. Coatings for braided medical devices and methods of forming same
CN109303577B (en) 2014-09-18 2021-05-28 波士顿科学国际有限公司 Device for a weight loss support allowing the pyloric sphincter to function normally
CN107530168B (en) 2015-05-01 2020-06-09 耶拿阀门科技股份有限公司 Device and method with reduced pacemaker ratio in heart valve replacement
EP4183371A1 (en) 2016-05-13 2023-05-24 JenaValve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US10568754B2 (en) 2016-05-13 2020-02-25 Boston Scientific Scimed, Inc. Protective apparatus for use in gastrointestinal tract
US10470904B2 (en) 2016-05-18 2019-11-12 Boston Scientific Scimed, Inc. Stent retrieval system
WO2017206155A1 (en) * 2016-06-03 2017-12-07 浦易(上海)生物技术有限公司 Weaving method for nasal sinus stent and stent obtained thereof
EP3538033B1 (en) 2016-11-10 2022-08-03 Medtronic Vascular Inc. Drug-filled stents to prevent vessel micro-injuries and methods of manufacture thereof
EP3538032A1 (en) 2016-11-10 2019-09-18 Medtronic Vascular Inc. Drug-filled stent with filaments for increased lumen surface area and method of manufacture thereof
JP7094965B2 (en) 2017-01-27 2022-07-04 イエナバルブ テクノロジー インク Heart valve imitation
US10945866B2 (en) 2017-08-14 2021-03-16 Boston Scientific Scimed, Inc. Medical stents
KR102436996B1 (en) 2017-10-25 2022-08-26 보스톤 싸이엔티픽 싸이메드 인코포레이티드 Stents with atraumatic spacers
WO2019224577A1 (en) 2018-05-23 2019-11-28 Sorin Group Italia S.R.L. A cardiac valve prosthesis
WO2020117756A1 (en) 2018-12-04 2020-06-11 Boston Scientific Scimed, Inc. Device for anastomotic bypass
US11389286B2 (en) 2018-12-05 2022-07-19 Boston Scientific Scimed, Inc. Esophageal atresia bridge device
US11364030B2 (en) 2019-02-15 2022-06-21 Boston Scientific Scimed, Inc. Medical device for treating esophageal atresia
JP7411800B2 (en) 2019-11-18 2024-01-11 ボストン サイエンティフィック サイムド,インコーポレイテッド Stents with improved anti-migration properties
CN116583247A (en) 2020-09-21 2023-08-11 波士顿科学国际有限公司 Lined stent facilitating stent removal
CN116456941A (en) 2020-09-24 2023-07-18 波士顿科学国际有限公司 Stent devices and methods for increasing patency of body openings

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059166A (en) * 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia
US5360440A (en) * 1992-03-09 1994-11-01 Boston Scientific Corporation In situ apparatus for generating an electrical current in a biological environment
US5824077A (en) * 1993-01-19 1998-10-20 Schneider (Usa) Inc Clad composite stent
US6387123B1 (en) * 1999-10-13 2002-05-14 Advanced Cardiovascular Systems, Inc. Stent with radiopaque core
US20080140176A1 (en) * 2006-10-18 2008-06-12 Krause Arthur A Medical stent and devices for localized treatment of disease

Family Cites Families (158)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3335443A (en) 1967-08-15 Ultrasonic brush
US2524661A (en) 1947-05-03 1950-10-03 Elgin Nat Watch Co Alloy having high elastic strengths
US3196876A (en) 1961-05-10 1965-07-27 Maurice M Miller Dilator
US3446166A (en) 1966-10-05 1969-05-27 Southern Textile Machinery Co Apparatus for inspecting and sewing stockings
NL145136C (en) 1967-07-25 1900-01-01
US3562024A (en) 1967-12-04 1971-02-09 Standard Pressed Steel Co Cobalt-nickel base alloys containing chromium and molybdenum
US3528410A (en) 1968-09-16 1970-09-15 Surgical Design Corp Ultrasonic method for retinal attachment
US3558066A (en) * 1969-01-21 1971-01-26 Howard Alliger Ultrasonic extraction of viable antigens from gram positive bacteria
US3584327A (en) 1969-04-04 1971-06-15 Fibra Sonics Ultrasonic transmission system
US3605750A (en) 1969-04-07 1971-09-20 David S Sheridan X-ray tip catheter
US3618614A (en) 1969-05-06 1971-11-09 Scient Tube Products Inc Nontoxic radiopaque multiwall medical-surgical tubings
US3618594A (en) 1970-04-06 1971-11-09 Surgical Design Corp Ultrasonic apparatus for retinal reattachment
US3930173A (en) 1971-06-15 1975-12-30 Surgical Design Corp Ultrasonic transducers
DE2219790C3 (en) 1972-04-22 1974-11-07 R Pohlman Device for generating brittle fractures in hard stones
US3805787A (en) 1972-06-16 1974-04-23 Surgical Design Corp Ultrasonic surgical instrument
US3861391A (en) 1972-07-02 1975-01-21 Blackstone Corp Apparatus for disintegration of urinary calculi
US3830240A (en) 1972-07-02 1974-08-20 Blackstone Corp Method and apparatus for disintegration of urinary calculi
US3749086A (en) 1972-07-24 1973-07-31 Medical Evaluation Devices & I Spring guide with flexible distal tip
DE2242863A1 (en) 1972-08-31 1974-03-14 Karl Storz SURGICAL ELEMENT FOR CRUSHING STONES IN THE HUMAN BODY BY ULTRASOUND
US3942519A (en) 1972-12-26 1976-03-09 Ultrasonic Systems, Inc. Method of ultrasonic cryogenic cataract removal
US4188952A (en) 1973-12-28 1980-02-19 Loschilov Vladimir I Surgical instrument for ultrasonic separation of biological tissue
US3956826A (en) 1974-03-19 1976-05-18 Cavitron Corporation Ultrasonic device and method
US3941122A (en) 1974-04-08 1976-03-02 Bolt Beranek And Newman, Inc. High frequency ultrasonic process and apparatus for selectively dissolving and removing unwanted solid and semi-solid materials and the like
US4023557A (en) 1975-11-05 1977-05-17 Uop Inc. Solar collector utilizing copper lined aluminum tubing and method of making such tubing
US4041931A (en) 1976-05-17 1977-08-16 Elliott Donald P Radiopaque anastomosis marker
CH630289A5 (en) 1977-05-09 1982-06-15 Bbc Brown Boveri & Cie HIGH DAMPING COMPOSITE.
US4370131A (en) 1977-06-24 1983-01-25 Surgical Design Ultrasonic transducer tips
DE2733019C3 (en) 1977-07-21 1981-01-15 Boris Samoilovitsch Gechman Device for crushing concretions in the ureter
US4425115A (en) 1977-12-19 1984-01-10 Wuchinich David G Ultrasonic resonant vibrator
US4202349A (en) 1978-04-24 1980-05-13 Jones James W Radiopaque vessel markers
CA1153264A (en) 1979-02-08 1983-09-06 Hidenaga Yoshimura Medical vascular guide wire and self-guiding type catheter
US4281419A (en) 1979-12-10 1981-08-04 Richards Manufacturing Company, Inc. Middle ear ossicular replacement prosthesis having a movable joint
US4657024A (en) 1980-02-04 1987-04-14 Teleflex Incorporated Medical-surgical catheter
US4295464A (en) 1980-03-21 1981-10-20 Shihata Alfred A Ureteric stone extractor with two ballooned catheters
FI59720C (en) 1980-04-02 1981-10-12 Outokumpu Oy COUPLING FOER LIVMODERINLAEGG SAMT FOERFARANDE FOER FRAMSTAELLNING AV DENSAMMA
DE3019996A1 (en) 1980-05-24 1981-12-03 Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen HOHLORGAN
EP0051975B1 (en) 1980-11-07 1987-03-11 David Baram A valve
US4465481A (en) 1981-02-26 1984-08-14 Innovative Surgical Products, Inc. Single piece wound drain catheter
US4406284B1 (en) 1981-03-20 1997-11-18 Surgical Design Corp Ultrasonic handpiece design
US4417578A (en) 1981-03-20 1983-11-29 Surgical Design Ultrasonic transducer with energy shielding
CA1204643A (en) 1981-09-16 1986-05-20 Hans I. Wallsten Device for application in blood vessels or other difficulty accessible locations and its use
US4425908A (en) 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
DE8132839U1 (en) 1981-11-10 1982-03-11 B. Braun Melsungen Ag, 3508 Melsungen REINFORCING CORE FOR A CATHETER TUBE
US4431006A (en) 1982-01-07 1984-02-14 Technicare Corporation Passive ultrasound needle probe locator
US4428379A (en) 1982-01-07 1984-01-31 Technicare Corporation Passive ultrasound needle probe locator
CH660882A5 (en) 1982-02-05 1987-05-29 Bbc Brown Boveri & Cie MATERIAL WITH A TWO-WAY MEMORY EFFECT AND METHOD FOR THE PRODUCTION THEREOF.
GB2116045B (en) 1982-03-04 1985-01-23 Wolf Gmbh Richard Piezoelectric transducers having a curved tubular shaft for disintegrating calculi
GB2116046B (en) 1982-03-04 1985-05-22 Wolf Gmbh Richard Apparatus for disintegrating and removing calculi
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
US4474180A (en) 1982-05-13 1984-10-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Apparatus for disintegrating kidney stones
US4464176A (en) 1982-06-04 1984-08-07 Mallinckrodt, Inc. Blood vessel catheter for medicine delivery and method of manufacture
US4535759A (en) 1982-09-30 1985-08-20 Cabot Medical Corporation Ultrasonic medical instrument
US4680031A (en) 1982-11-29 1987-07-14 Tascon Medical Technology Corporation Heart valve prosthesis
US4892541A (en) * 1982-11-29 1990-01-09 Tascon Medical Technology Corporation Heart valve prosthesis
CH653369A5 (en) 1983-03-14 1985-12-31 Bbc Brown Boveri & Cie COMPOSITE MATERIAL IN BAR, TUBE, STRIP, SHEET OR PLATE SHAPE WITH REVERSIBLE THERMO-MECHANICAL PROPERTIES AND METHOD FOR THE PRODUCTION THEREOF.
JPS60501696A (en) 1983-06-28 1985-10-11 シユテリメ−ト ゲゼルシヤフト フユ−ル メデイツイ−ニツシエンベダルフ ミツト ベシユレンクテル ハフツング Medical devices with introduction aids
US4517793A (en) 1983-08-23 1985-05-21 Vernon-Carus Limited Radio opaque fibre
CA1232814A (en) * 1983-09-16 1988-02-16 Hidetoshi Sakamoto Guide wire for catheter
US4719916A (en) 1983-10-03 1988-01-19 Biagio Ravo Intraintestinal bypass tube
JPS6082648A (en) 1983-10-08 1985-05-10 Agency Of Ind Science & Technol Process for forming material having high strength and difficult processability
US4572184A (en) 1983-10-28 1986-02-25 Blackstone Corporation Wave guide attachment means and methods
US4848348A (en) 1983-11-14 1989-07-18 Minnesota Mining And Manufacturing Company Coated films
US4654092A (en) 1983-11-15 1987-03-31 Raychem Corporation Nickel-titanium-base shape-memory alloy composite structure
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
JPS60126170A (en) 1983-12-14 1985-07-05 テルモ株式会社 Catheter and its production
SE452404B (en) 1984-02-03 1987-11-30 Medinvent Sa MULTILAYER PROTEST MATERIAL AND PROCEDURE FOR ITS MANUFACTURING
CA1237482A (en) 1984-03-09 1988-05-31 Frank B. Stiles Catheter for effecting removal of obstructions from a biological duct
US4577637A (en) 1984-07-13 1986-03-25 Argon Medical Corp. Flexible metal radiopaque indicator and plugs for catheters
US4697595A (en) 1984-07-24 1987-10-06 Telectronics N.V. Ultrasonically marked cardiac catheters
YU132884A (en) 1984-07-26 1987-12-31 Branko Breyer Electrode cateter with ultrasonic marking
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
SE452110B (en) 1984-11-08 1987-11-16 Medinvent Sa MULTILAYER PROTEST MATERIAL AND PROCEDURE FOR ITS MANUFACTURING
US4602633A (en) 1984-11-16 1986-07-29 Blackstone Corporation Methods and apparatus for disintegration of urinary calculi under direct vision
ES8705239A1 (en) 1984-12-05 1987-05-01 Medinvent Sa A device for implantation and a method of implantation in a vessel using such device.
DE3447642C1 (en) 1984-12-28 1986-09-18 Bernhard M. Dr. 5600 Wuppertal Cramer Steerable guidewire for catheters
US4629458A (en) 1985-02-26 1986-12-16 Cordis Corporation Reinforcing structure for cardiovascular graft
CH665784A5 (en) 1985-03-21 1988-06-15 Hansen Dieter Ag ULTRASONIC MACHINE TOOL.
SE450809B (en) 1985-04-10 1987-08-03 Medinvent Sa PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS
SE447061B (en) 1985-06-10 1986-10-27 Medinvent Sa INFO DEVICE, SPEC FOR IMPLEMENTATION IN A LIVE ORGANISM
US4816018A (en) 1985-08-02 1989-03-28 Ultramed Corporation Ultrasonic probe tip
US4750902A (en) 1985-08-28 1988-06-14 Sonomed Technology, Inc. Endoscopic ultrasonic aspirators
US4750488A (en) 1986-05-19 1988-06-14 Sonomed Technology, Inc. Vibration apparatus preferably for endoscopic ultrasonic aspirator
US4698058A (en) 1985-10-15 1987-10-06 Albert R. Greenfeld Ultrasonic self-cleaning catheter system for indwelling drains and medication supply
US4823793A (en) 1985-10-30 1989-04-25 The United States Of America As Represented By The Administrator Of The National Aeronuautics & Space Administration Cutting head for ultrasonic lithotripsy
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4830262A (en) 1985-11-19 1989-05-16 Nippon Seisen Co., Ltd. Method of making titanium-nickel alloys by consolidation of compound material
US4748986A (en) 1985-11-26 1988-06-07 Advanced Cardiovascular Systems, Inc. Floppy guide wire with opaque tip
DE3640745A1 (en) * 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
US4681110A (en) 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4724846A (en) 1986-01-10 1988-02-16 Medrad, Inc. Catheter guide wire assembly
EP0556940A1 (en) 1986-02-24 1993-08-25 Robert E. Fischell Intravascular stent
US4731084A (en) 1986-03-14 1988-03-15 Richards Medical Company Prosthetic ligament
US4867173A (en) 1986-06-30 1989-09-19 Meadox Surgimed A/S Steerable guidewire
US4819618A (en) 1986-08-18 1989-04-11 Liprie Sam F Iridium/platinum implant, method of encapsulation, and method of implantation
SE454482B (en) 1986-09-30 1988-05-09 Medinvent Sa DEVICE FOR IMPLANTATION
SE455834B (en) 1986-10-31 1988-08-15 Medinvent Sa DEVICE FOR TRANSLUMINAL IMPLANTATION OF A PRINCIPLE RODFORMALLY RADIALLY EXPANDABLE PROSTHESIS
US4793348A (en) 1986-11-15 1988-12-27 Palmaz Julio C Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation
US4748971A (en) 1987-01-30 1988-06-07 German Borodulin Vibrational apparatus for accelerating passage of stones from ureter
US4817600A (en) 1987-05-22 1989-04-04 Medi-Tech, Inc. Implantable filter
US4796637A (en) 1987-06-17 1989-01-10 Victory Engineering Company Radiopaque marker for stereotaxic catheter
US4989608A (en) * 1987-07-02 1991-02-05 Ratner Adam V Device construction and method facilitating magnetic resonance imaging of foreign objects in a body
JPS6458263A (en) * 1987-08-28 1989-03-06 Terumo Corp Intravascular introducing catheter
AU614092B2 (en) * 1987-09-11 1991-08-22 Paul Max Grinwald Improved method and apparatus for enhanced drug permeation of skin
AU623100B2 (en) * 1987-10-08 1992-05-07 Terumo Kabushiki Kaisha Instrument and apparatus for securing inner diameter of lumen of tubular organ
US4870953A (en) 1987-11-13 1989-10-03 Donmicheal T Anthony Intravascular ultrasonic catheter/probe and method for treating intravascular blockage
US4830023A (en) 1987-11-27 1989-05-16 Medi-Tech, Incorporated Medical guidewire
US4906241A (en) * 1987-11-30 1990-03-06 Boston Scientific Corporation Dilation balloon
US4846186A (en) 1988-01-12 1989-07-11 Cordis Corporation Flexible guidewire
US4907572A (en) * 1988-04-14 1990-03-13 Urological Instruments Research, Inc. Vibrational method for accelerating passage of stones from ureter
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4995878A (en) * 1988-07-15 1991-02-26 Rai Dinker B Method for descending venography
US4920954A (en) * 1988-08-05 1990-05-01 Sonic Needle Corporation Ultrasonic device for applying cavitation forces
US4980964A (en) * 1988-08-19 1991-01-01 Jan Boeke Superconducting wire
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
SE8803444D0 (en) * 1988-09-28 1988-09-28 Medinvent Sa A DEVICE FOR TRANSLUMINAL IMPLANTATION OR EXTRACTION
US5207706A (en) * 1988-10-05 1993-05-04 Menaker M D Gerald Method and means for gold-coating implantable intravascular devices
US4984581A (en) * 1988-10-12 1991-01-15 Flexmedics Corporation Flexible guide having two-way shape memory alloy
US5019085A (en) * 1988-10-25 1991-05-28 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US5001825A (en) * 1988-11-03 1991-03-26 Cordis Corporation Catheter guidewire fabrication method
US4899733A (en) * 1988-12-19 1990-02-13 Blackstone Ultrasonic, Inc. Device and technique for transurethral ultrasonic lithotripsy using a flexible ureteroscope
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
US4922924A (en) * 1989-04-27 1990-05-08 C. R. Bard, Inc. Catheter guidewire with varying radiopacity
US5003989A (en) * 1989-05-11 1991-04-02 Advanced Cardiovascular Systems, Inc. Steerable dilation catheter
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5111829A (en) * 1989-06-28 1992-05-12 Boston Scientific Corporation Steerable highly elongated guidewire
US5015183A (en) * 1989-08-07 1991-05-14 Fenick Thomas J Locating device and method of placing a tooth implant
US5674278A (en) * 1989-08-24 1997-10-07 Arterial Vascular Engineering, Inc. Endovascular support device
CA2026604A1 (en) * 1989-10-02 1991-04-03 Rodney G. Wolff Articulated stent
US5176617A (en) * 1989-12-11 1993-01-05 Medical Innovative Technologies R & D Limited Partnership Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct
US5012797A (en) * 1990-01-08 1991-05-07 Montefiore Hospital Association Of Western Pennsylvania Method for removing skin wrinkles
US5095915A (en) * 1990-03-19 1992-03-17 Target Therapeutics Guidewire with flexible distal tip
US5109830A (en) * 1990-04-10 1992-05-05 Candela Laser Corporation Apparatus for navigation of body cavities
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5276455A (en) * 1991-05-24 1994-01-04 The Boeing Company Packaging architecture for phased arrays
US5213111A (en) * 1991-07-10 1993-05-25 Cook Incorporated Composite wire guide construction
CA2380683C (en) * 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
JPH07505316A (en) * 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
US5380273A (en) * 1992-05-19 1995-01-10 Dubrul; Will R. Vibrating catheter
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5397293A (en) * 1992-11-25 1995-03-14 Misonix, Inc. Ultrasonic device with sheath and transverse motion damping
US5630840A (en) * 1993-01-19 1997-05-20 Schneider (Usa) Inc Clad composite stent
DE69433774T2 (en) * 1993-02-19 2005-04-14 Boston Scientific Corp., Natick SURGICAL EXTRACTOR
JP3464249B2 (en) * 1993-09-03 2003-11-05 ヤマハマリン株式会社 Waterproof structure of outboard engine
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
DE69419877T2 (en) * 1993-11-04 1999-12-16 Bard Inc C R Fixed vascular prosthesis
US5556413A (en) * 1994-03-11 1996-09-17 Advanced Cardiovascular Systems, Inc. Coiled stent with locking ends
US6001123A (en) * 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US6033719A (en) * 1996-04-25 2000-03-07 Medtronic, Inc. Method for covalent attachment of biomolecules to surfaces of medical devices
US5891191A (en) * 1996-04-30 1999-04-06 Schneider (Usa) Inc Cobalt-chromium-molybdenum alloy stent and stent-graft
US5733326A (en) * 1996-05-28 1998-03-31 Cordis Corporation Composite material endoprosthesis
US6027528A (en) * 1996-05-28 2000-02-22 Cordis Corporation Composite material endoprosthesis
US5858556A (en) * 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US6015432A (en) * 1998-02-25 2000-01-18 Cordis Corporation Wire reinforced vascular prosthesis
US6206915B1 (en) * 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059166A (en) * 1989-12-11 1991-10-22 Medical Innovative Technologies R & D Limited Partnership Intra-arterial stent with the capability to inhibit intimal hyperplasia
US5360440A (en) * 1992-03-09 1994-11-01 Boston Scientific Corporation In situ apparatus for generating an electrical current in a biological environment
US5824077A (en) * 1993-01-19 1998-10-20 Schneider (Usa) Inc Clad composite stent
US6387123B1 (en) * 1999-10-13 2002-05-14 Advanced Cardiovascular Systems, Inc. Stent with radiopaque core
US20080140176A1 (en) * 2006-10-18 2008-06-12 Krause Arthur A Medical stent and devices for localized treatment of disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090192587A1 (en) * 2005-10-03 2009-07-30 Cardiatis S.A. Radio-opaque endoprosthesis
US8353951B2 (en) * 2005-10-03 2013-01-15 Cardiatis S.A. Radio-opaque endoprosthesis

Also Published As

Publication number Publication date
US20040138740A1 (en) 2004-07-15
US20020035396A1 (en) 2002-03-21
US7101392B2 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
US7101392B2 (en) Tubular medical endoprostheses
US6290721B1 (en) Tubular medical endoprostheses
US6887265B2 (en) Balloon expandable covered stents
US6248190B1 (en) Process of making composite stents with gold alloy cores
EP0947204B1 (en) Composite material endoprosthesis
JP4652375B2 (en) Endoprosthesis
US6527802B1 (en) Clad composite stent
US5628787A (en) Clad composite stent
US20090276033A1 (en) Clad Composite Stent
US8435280B2 (en) Flexible stent with variable width elements

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION